Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Gazyva-Calquence Combo Filed in Japan for CLL: Chugai/AstraZeneca
March 8, 2022
- Japan Ethical Drug Sales Up 5.8% in January: Crecon
March 8, 2022
- Oncolys, NIID Team Up to Unlock Oral COVID-19 Med’s Mechanism of Action
March 8, 2022
- Big 3 Japan Generic Makers See Average 8.2% Price Cut in FY2022: Jiho Poll
March 7, 2022
- Shionogi’s COVID-19 Jab Non-Inferior to Pfizer Shot in Japan Booster Trial
March 7, 2022
- Eisai Suffers 9%-Plus Cut, Sumitomo Dainippon Over 8% in 2022 Drug Price Revision: Jiho Poll
March 7, 2022
- Eisai Begins Data Submission for Lecanemab for Swift Approval in Japan
March 7, 2022
- AZ Japan Working towards 100% Electric Vehicle Fleet by 2025, but Challenges Remain
March 3, 2022
- Sumitomo Dainippon to Succeed Fabrazyme Biosimilar Sales from JCR
March 2, 2022
- Trulicity, Rybelsus Might Gain Ground in GLP-1 Market amid Ozempic Supply Woes
March 2, 2022
- Astellas Returns Rights for Pneumococcal Vaccine to Affinivax on Strategic Prioritization
March 2, 2022
- Sanwa Kagaku Bags Japan Rights to Crinetics’ Paltusotine
March 2, 2022
- EA Pharma Licenses Secondary Hyperparathyroidism Drug to US Firm
March 2, 2022
- Key EU Panel Backs Padcev Again for Bladder Cancer
March 2, 2022
- Zogenix Sees Its Pipeline Drugs Continue to Be Developed in Japan after UCB Deal
March 2, 2022
- Drugs Might Get Hit by SWIFT Ban on Russia Even If Exempted from Trade Sanctions
March 1, 2022
- Ozempic Shipment Suspension Expected from March: Novo
March 1, 2022
- Ono Sues AstraZeneca over PD-L1 Patent, Seeks 32 Billion Yen in Damage
March 1, 2022
- Shionogi, Ube Tie Up on Anti-RSV Drug, Eye Clinical Trial Launch in FY2023
March 1, 2022
- Mitsubishi Tanabe Snaps Up Seed Compounds through Research Collaboration with Chinese Biotech
February 28, 2022
ページ
Japan is opening a new chapter in sleep medicine. The recent decision to allow medical institutions to advertise “sleep disorders”…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…